PortViewPortView
Decoy Therapeutics logo

Decoy Therapeutics (DCOY) Stock Analysis

NASDAQHealthcareBiotechnology

$1.08+4.85%
1-year price historyRange $0.92 – $46.68
52-week range$1.08
$0.90$47.28

Track DCOY in your portfolio for free · Portfolio tracker

What Decoy Therapeutics does

Based in Cambridge, Massachusetts, Decoy Therapeutics Inc. is an early-stage biotechnology firm dedicated to tackling critical unmet medical needs. The company employs cutting-edge machine learning and AI technologies, alongside accelerated synthesis methods, to swiftly design, engineer, and manufacture innovative peptide conjugate drug candidates.

Key metrics

Market cap
$574,525
P/E (TTM)
-0.01
EPS (TTM)
$-112.73
Beta
0.58
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$2.30
200-day avg
$5.67
52-week high
$47.28
52-week low
$0.90
CEO
Frederick E. Pierce

ETFs linked to DCOY

Broad-market and Healthcare sector ETFs an investor holding Decoy Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how DCOY fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze DCOY in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Decoy Therapeutics?
Decoy Therapeutics trades under the ticker DCOY on NASDAQ.
Which exchange is DCOY listed on?
DCOY is listed on NASDAQ.
What sector does Decoy Therapeutics operate in?
Decoy Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze DCOY in a portfolio?
PortView shows DCOY's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.